Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FEDWF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,728
Award facts
- Contract value 100% obligated
- $38,727.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $38,727.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of RINVOQ ER 30 mg tablets in quantities of 30 units. This contract is a non-set-aside competitive award with a completion date of June 20, 2025, with performance to be completed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. RINVOQ (upadacitinib) is a Janus kinase inhibitor indicated for the treatment of rheumatoid arthritis and other inflammatory conditions, and this delivery order represents a specific pharmaceutical procurement requirement for federal military healthcare operations.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide and serves customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's extensive federal contract portfolio and competitive awards demonstrate its capability as a critical vendor for federal medical procurement needs, particularly within the Defense Logistics Agency's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DB25FEDWF?
SPE2DB25FEDWF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FEDWF worth?
The government has obligated $38,728 on SPE2DB25FEDWF.
Is contract SPE2DB25FEDWF an order under another contract?
Yes. SPE2DB25FEDWF is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEDWF competed?
The extent of competition for SPE2DB25FEDWF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award